Company Legal Name
Latest Valuation
Founded Year
Headquarters
PathAI, Inc. develops cloud-based artificial intelligence solutions that enable pathologists to analyze tissue samples with enhanced accuracy and efficiency. Founded in 2016 and headquartered in Boston, the company leverages machine learning algorithms to assist in diagnostic pathology, helping healthcare providers improve patient outcomes through more precise disease detection and treatment recommendations. PathAI's platform addresses critical challenges in pathology, including diagnostic variability and workflow inefficiencies that plague traditional manual analysis methods. The company focuses on expanding its AI-powered diagnostic capabilities across various disease areas while building strategic partnerships with pharmaceutical companies, research institutions, and healthcare systems to accelerate adoption of precision medicine solutions.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
